Trade AbbVie ABBV

AbbVie live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

AbbVie News

Emma Rose 2025 Nov 22, 00:00

Citadel Securities' Rubner: S&P 500's 'Healthy' Pullback Sets Stage for Year-End Rally

Sophia Claire 2025 Nov 22, 00:00

Ray Dalio: Why You Shouldn't Abandon AI Despite Bubble Concerns

Emma Rose 2025 Nov 21, 00:00

US Nonfarm Payrolls: September's Delayed Report and Fed Rate Hike Speculation

Ava Grace 2025 Nov 21, 00:00

US Repo Market Liquidity Concerns Linger Despite Fed Easing

Frances Wang 2025 Nov 20, 16:00

AI stock analysis: BBAI stock slides 5% today, what happened to BigBear.ai?

Ghko B 2025 Nov 20, 16:00

What moved META stock today: Should You Buy the Dip on Meta Stock?

Frances Wang 2025 Nov 20, 16:00

Gold price XAUUSD analysis: XAU/USD remains neutral, what’s next?

Ghko B 2025 Nov 19, 16:00

Best AI Stocks to Buy 2026: CoreWeave (CRWV) Stock, Nvidia (NVDA), AVGO

Frances Wang 2025 Nov 19, 16:00

XRP price forecast: XRP price keeps falling, is XRP expected to go up?

Frances Wang 2025 Nov 18, 16:00

BTC/USD prediction: Bitcoin dips below $92K, will bitcoin bounce back?

Latest news

Show more
Sophia Claire 2025 Nov 22, 10:30

Solo Bitcoin Miner Hits Jackpot, Earning $266K Against All Odds

Liam James 2025 Nov 22, 09:20

Crypto Market Updates: Bitmain Investigation, Tom Lee's Outlook, and Institutional Holdings Surge

Liam James 2025 Nov 22, 07:50

MicroStrategy's Index Exclusion Risk: Is the Stock-for-Bitcoin Era Over?

Liam James 2025 Nov 22, 07:40

ARK Invest Continues Crypto Buying Spree: Bullish, Circle, and Bitcoin ETFs Targeted

Noah Lee 2025 Nov 22, 06:30

Ethereum at a Crossroads: Quantum Threats & Wall Street Dominance

Liam James 2025 Nov 22, 05:50

Bitcoin Halving Cycle Analysis: Is the Four-Year Cycle Still Valid in 2025?

Ava Grace 2025 Nov 22, 02:30

Arc Blockchain Testnet Guide: Potential Opportunities with USDC as Gas Fee

Sophia Claire 2025 Nov 22, 02:20

Bitcoin Price Catalyst: Sovereign Adoption and Quantum Computing Clarity

Info

Spread

1.45

Spread (%)

0.6161 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

405526380544

Shares Outstanding

1767384632

Earnings Date (Next)

0000-00-00

Div Yield

2026-02-17

Ex-Dividend Date

2026-01-16

Forward annual dividend rate

6.92

Forward annual dividend yield

0.0297

EPS

1.31

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 20, 16:00

What Are Privacy Coins: Top 3 Privacy Coins, Do Privacy Coins Have a Future?

Ghko B 2025 Nov 20, 16:00

CFD Trading Explained: Understanding the Basics and Benefits of CFD

Ghko B 2025 Nov 20, 16:00

10 Best Ways to trade Cryptos as Beginner: How to Make Money with Cryptos?

Trustpilot